P2.06-014 Phase 2 Study of Glesatinib or Sitravatinib with Nivolumab in Non-Small Cell Lung Cancer (NSCLC) after Checkpoint Inhibitor Therapy: Topic: Phase II + NK.

Details

Language :

English

ISSN :

15560864

Volume :

12

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

120520471

Full Text :

https://doi.org/10.1016/j.jtho.2016.11.1507